RAPPORT THERAPEUTICS INC (RAPP:NASDAQ)

$39.51 -0.2 (-0.5037%)

watchlist-icon
search-icon
Profile Icon

Most Recent Average Sentiment Analysis Score (0 to 100): 78

negative-sentiment
Negative [0, 35)
neutral-sentiment
Neutral [35, 65]
positive-sentiment
Positive (65, 100]
Visualize Sentiment Trendline

Analysed RAPPORT THERAPEUTICS INC (RAPP:NASDAQ) News Sources

This $64 Million Biotech Exit Seemingly Missed a 77% One-Day Surge on Gilead Takeover Deal

16-03-2026

fool.com

How Investors May Respond To Rapport Therapeutics (RAPP) Licensing RAP-219 To Tenacia In Greater China

21-03-2026

yahoo.com

All You Need to Know About Rapport Therapeutics, Inc. (RAPP) Rating Upgrade to Buy

26-03-2026

yahoo.com

Rapport Therapeutics to Present New Phase 2 Treatment Follow-Up Data for RAP-219 in Focal Onset Seizures at the 2026 American Academy of Neurology Annual Meeting

01-04-2026

yahoo.com

Rapport Therapeutics Presents RAP-219 Focal Onset Seizure Phase 2a Follow-up Period Results Demonstrating Sustained Seizure Reduction at the 2026 American Academy of Neurology Annual Meeting

21-04-2026

yahoo.com

Rapport Insider Sells $17.2 Million as Stock Surges 230% in a Year and Phase 3 Trials Near

27-04-2026

fool.com

Rapport Therapeutics Insiders Added US$1.61m Of Stock To Their Holdings

30-04-2026

yahoo.com

Rapport Therapeutics Reports First Quarter 2026 Financials and Provides Business Update

07-05-2026

yahoo.com

Rapport Therapeutics, Inc. (RAPP) Reports Q1 Loss

07-05-2026

yahoo.com

Rapport Therapeutics to Participate in the Jefferies Global Healthcare Conference and Goldman Sachs 47th Annual Global Healthcare Conference

20-05-2026

yahoo.com

RAPPORT THERAPEUTICS INC (RAPP:NASDAQ) Sentiment Trend

0 25 50 75 100 91 86 88 86 70 91 91 85 2 86 16-03-2026 21-03-2026 26-03-2026 01-04-2026 21-04-2026 27-04-2026 30-04-2026 07-05-2026 20-05-2026 #1 #2 #3 #4 #5 #6 #7 #8 #9 #10 Negative < 35 Neutral 35–65 Positive > 65 View FAQ

RAPPORT THERAPEUTICS INC (RAPP:NASDAQ) FAQs

toggle

What is the current price of RAPPORT THERAPEUTICS INC (RAPP:NASDAQ)?

The current price of RAPPORT THERAPEUTICS INC (RAPP:NASDAQ) is $39.51.


toggle

RAPPORT THERAPEUTICS INC (RAPP:NASDAQ) absolute price change since previous trading day?

The absolute price change of RAPPORT THERAPEUTICS INC (RAPP:NASDAQ) since the previous trading day is $-0.2.


toggle

RAPPORT THERAPEUTICS INC (RAPP:NASDAQ) percentage price change since previous trading day?

The percentage price change of RAPPORT THERAPEUTICS INC (RAPP:NASDAQ) since the previous trading day is -0.5037%.


toggle

What is the most recent average sentiment score for RAPPORT THERAPEUTICS INC (RAPP:NASDAQ)?

The most recent average sentiment score for RAPPORT THERAPEUTICS INC (RAPP:NASDAQ) is 78 out of 100.


toggle

What is the most recent average sentiment for RAPPORT THERAPEUTICS INC (RAPP:NASDAQ)?

The most recent sentiment for RAPPORT THERAPEUTICS INC (RAPP:NASDAQ) is .


SEC-8K** Filing Available For RAPPORT THERAPEUTICS INC (RAPP:NASDAQ)

** material developments that could impact a company's financial condition or stock price.

Author: MattELab

X Icon

GitHub Icon

MattELab is the founder and lead developer of SentientMerchant. With a Computer Science and Quantitative Finance background from a T10 university, he brings over 6 years of expertise in NLP, programmatic SEO, and full-stack development to build highly scalable AI and FinTech solutions.